These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of lidoflazine as an anti-anginal drug. Vohra JK, Sloman JG. Cardiology; 1973; 58(4):209-19. PubMed ID: 4206284 [No Abstract] [Full Text] [Related]
3. Lidoflazine: double-blind trial of a new coronary vasodilator in angina pectoris. Brantmark B, Egelius N, Fabricius E, Jemt M, Palmborg G, Philipson J, Rönnegård N. Eur J Clin Pharmacol; 1973 Oct; 6(3):156-62. PubMed ID: 4202654 [No Abstract] [Full Text] [Related]
4. [Efficacy of lidoflazine in angina pectoris. A long-term double-blind study]. Lehmann H, Hochrein H. Med Klin; 1976 Jan 30; 71(5):189-96. PubMed ID: 814396 [Abstract] [Full Text] [Related]
5. Long-term evaluation of lidoflazine in angina pectoris based on exercise tolerance. Piessens J, De Geest H. Cardiology; 1972 Jan 30; 57(3):135-49. PubMed ID: 4557527 [No Abstract] [Full Text] [Related]
10. Lidoflazine and physical training in the treatment of stable angina pectoris. Ferguson RJ, Côté P, Bourassa MG, Corbara F. Clin Cardiol; 1979 Dec 30; 2(6):413-6. PubMed ID: 397017 [Abstract] [Full Text] [Related]
19. [Lidoflazine in angina pectoris. I. Double blind study]. Batlouni M, Betolami V, Duprat R. Arq Bras Cardiol; 1968 Oct 30; 21(5):321-6. PubMed ID: 4886984 [No Abstract] [Full Text] [Related]